Efficacy and Safety of Oral Supplementation with Liposomal Iron in Non-Dialysis Chronic Kidney Disease Patients with Iron Deficiency.
Davide CesaranoSilvio BorrelliGiorgia CampilongoAnnarita D'AmbraFederica PapadiaCarlo GarofaloAntonia De MarcoFederica MarzanoChiara RuotoloLoreto GesualdoPietro CirilloRoberto MinutoloPublished in: Nutrients (2024)
The use of liposomal iron in patients with NDD-CKD is associated with a partial correction of transferrin saturation, with no significant effect on iron storage and Hb levels.